|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Jul 25, 2018 |
Title |
s_HAS_1 |
Sample type |
SRA |
|
|
Source name |
Saline control for Poly(I:C) study
|
Organism |
Mus musculus |
Characteristics |
tissue: forebrain microglia protocol: RiboTag
|
Extracted molecule |
total RNA |
Extraction protocol |
To investigate alterations in the microglial translatome during normal aging, systemic inflammation, amyloidoisis and tauopathy, RNA was isolated from microglia using the RiboTag translational Cre/Lox-based profiling system for microglial transcript isolation based on expression of a hemagluttanin (HA) epitope-tagged core ribosomal protein (RPL22) in a cell type of interest. A tamoxifen inducible Cx3cr1 promoter for Cre and eYFP expression (Cx3cr1-CreERT2-IRES-eYFP was crossed to RiboTag mice to generate double heterozygous Cx3cr1CreERT2-IRES-eYFP/+; Rpl22HA/+ mice (referred to as RiboTag). For comparisons of RiboTag vs cellular isolation strategies at baseline and following LPS injection, microglia were also isolated from the forebrain of PBS perfused tamoxifen injected RiboTag mice using cellular isolation strategies where cells underwent a 20 minute collagenase enzymatic digestion followed by a Percoll gradient for myelin removal and sorting based on staining for CD45 and CD11b (7AAD- CD11b+ CD45lo/int microglial population were sorted to >98% purity). Cells were sorted into Buffer RLT supplemented with 2-β-mercaptoethanol and RNA was isolated using a Qiagen RNeasy microkit with in column DNaseI digestion. For all RiboTag studies, RiboTag mice (Cx3Cr1cre/+; Rpl22HA/+) were injected for 3 consecutive days with 100μg/g tamoxifen and allowed to rest for a week prior to harvesting or systemic challenge followed by harvest. PBS perfused forebrains were immediately sonicated in homogenization buffer (50mM Tris pH 7.4, 100mM KCl, 12mM MgCl2, 1% NP-40) supplemented with 1mM DTT, 1x protease/phosphatase inhibitors, 200U/mL RNAsin, 100 μg/mL cycloheximide, and 1mg/mL heparin. Lysates were centrifuged at 4°C at 10,000g for 10 minutes. Supernatants were incubated with anti-HA antibodies and rotated at 4°C for 4 hours prior to incubation with protein G magnetic beads overnight at 4°C while rotating. Beads were magnetized and non-HA containing supernatants were removed prior to washing with a high salt buffer (50mM Tris, 300mM KCl, 12mM MgCl2, 10% NP-40, 1mM DTT, 100μg/mL cycloheximide). Three washes were conducted prior to magnetizing the beads, removing all supernatants and then releasing HA bound transcripts from the beads using Buffer RLT supplemented with 2-β-mercaptoethanol. RNA was purified using a Qiagen RNeasy microkit followed by in-column DNase I treatment according to manufacturer’s instructions. For LPS and poly I:C studies, animals were injected with 2μg/g LPS or 12μg/g poly I:C intraperitoneally (i.p.), respectively and microglial were isolated 24 hours post systemic challenge. For amyloidosis studies, 9-10 month old male APPswe/PS1ΔE9 (APP/PS1) and littermate controls were used for RNAseq studies. For tauopathy studies, 9-10 month old male Cx3Cr1creER/+; Rpl22HA/+ that were injected previously injected intracerebroventricularly (ICV) with 2.7E+10 viral particles/ventricle and 2uL/ventricle of rAAV1-TauP301L and rAAV1-GFP on postnatal day 0 were used for to isolate RNA. Finally, in the normal aging study, male or female RiboTag mice (Cx3Cr1cre/+; Rpl22HA/+) were harvested at either 3 months (young), 12 months (middle), or 24 months (old) of age for RiboTag mediated RNA isolation. Samples were amplified for RNAseq by cDNA library preparation using a NuGen Ovation RNA v2 kit (NuGen, San Carlos, CA) according to manufacturer’s instructions.
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina HiSeq 4000 |
|
|
Data processing |
Base calling by CASAVA Alignment by Tophat2 Gene count by featureCount Normalization by RPKM Genome_build: mm10 Supplementary_files_format_and_content: excel file for rpkm values of genes
|
|
|
Submission date |
Jul 25, 2018 |
Last update date |
Jul 26, 2018 |
Contact name |
Xuewei Wang |
Organization name |
Mayo Clinic
|
Street address |
200 1st street
|
City |
Rochester |
ZIP/Postal code |
55902 |
Country |
USA |
|
|
Platform ID |
GPL21103 |
Series (1) |
GSE117646 |
Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau |
|
Relations |
BioSample |
SAMN09714704 |
SRA |
SRX4456578 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|